Intrinsiqq
Medirom Healthcare Technologies Inc. logo

Medirom Healthcare Technologies Inc. Intrinsic Value

MRM

Compare

Choose a model

Each card values Medirom Healthcare Technologies a different way, shown at our starting inputs. Pick one to see and change how it works.

Set your assumptions

Medirom Healthcare Technologies on revenue: sales per share grow and the stock trades at a normal price-to-sales multiple. For companies not yet profitable.

Years to project

Growth of revenue per share

Revenue per share; starts at its own recent growth

Exit P/S

Starts at its industry's median P/S

Your desired return

Margin of safety

More

Your buy price

The expected return is measured from it; starts at today's price

How it's worked out

  1. Today's revenue per share

    Last twelve months

    ¥1,418.29

  2. Revenue in 2031

    Grows 8.5% a year for 5 years

    ¥2,132.62

  3. Price in 2031

    ¥2,132.62 × 0.8 P/S

    ¥1,706.09

  4. Worth today

    ÷ 1.10^5: your 10% a year, taken back out

    ¥1,059.35

  5. Fair value

    The most you can pay and still earn 10% a year

    ¥1,059.35

  6. Buy below

    Fair value minus your 25% margin of safety

    ¥794.51

Every rule is on the methodology page.

Outcome

What your assumptions give, and the path from today's price.

Fair value

¥1,059.35

Expected return

Set a buy price

Future price, 2031

¥1,706.09

Buy below

¥794.51

MRM trades as a depositary receipt that can stand for several ordinary shares, and its filings count ordinary shares. We show the value per ordinary share and leave out the price comparison rather than guess the ratio.

Projection

Solid blue: the price at each year end. Dashed blue: from today's price to the 2031 price. Green: from the fair value, rising at your 10% a year to the same end point; buy at or below it and you earn at least that. Every rule is on the methodology page. A model, not a forecast or advice.

Medirom Healthcare Technologies (MRM) intrinsic value and fair value

The calculator grows one of Medirom Healthcare Technologies's per-share figures (earnings, free cash flow, revenue, book value or dividends) for a few years, puts an exit multiple on it, and discounts the result back at the yearly return you want. The answers below use its starting inputs for MRM; this is analysis, not investment advice.

Frequently asked

What is Medirom Healthcare Technologies's (MRM) intrinsic value?+

With Intrinsiqq's starting inputs, Medirom Healthcare Technologies's fair value is about ¥1,059.35 a share, based on its revenue per share. That assumes revenue per share of ¥1,418.29 grows about 8.5% a year for 5 years, the stock then trades at 0.8 times revenue, and you want a 10.0% yearly return. On its other figures: earnings ¥731.48. Every input can be changed on the page; the result is a model, not a forecast.

What growth does the Medirom Healthcare Technologies valuation assume?+

Revenue per share grows about 8.5% a year to start, its own recent growth per share (three years for a company not yet profitable, five otherwise). The exit multiple starts at its industry's median.

What is a good margin of safety for Medirom Healthcare Technologies?+

A margin of safety is the cushion you want below the fair value before buying, in case the inputs are wrong. The calculator uses 25%, which puts the buy-below price at ¥794.51. Less predictable businesses deserve a wider cushion, or a higher desired return.

How the market compares: US profitability statistics

SourceFair value computed from the 10-K filed 29 Apr 2025, covering the period ending 31 Dec 2024, as reported to the SEC. Data last refreshed 17 Apr 2026. How this is calculated.

Price from market data, last close as of 20 Nov 2026. Fiscal year ends Dec.

Peers

Services-Personal Services · Pick stocks to compare with MRM

CompareIntrinsic value
SCIService Corporation International
$69.14-0.22%64
HRBH&R Block Inc.
$46.01-0.95%63
UNFUniFirst Corp.
$228.74-0.72%56
YELPYelp Inc.
$18.19-1.99%94

Spot a number that looks wrong? Check it in MRM's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing MRM

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.